Hidekazu Kuramochi

Summary

Affiliation: Tokyo Women's Medical University
Country: Japan

Publications

  1. pmc Amphiregulin and Epiregulin mRNA expression in primary colorectal cancer and corresponding liver metastases
    Hidekazu Kuramochi
    Department of Chemotherapy and Palliative Care, Tokyo Women s Medical University, 8 1 Kawadacho, Shinjukuku, Tokyo, Japan
    BMC Cancer 12:88. 2012
  2. doi High intratumoral dihydropyrimidine dehydrogenase mRNA levels in pancreatic cancer associated with a high rate of response to S-1
    Hidekazu Kuramochi
    Department of Gastroenterology, Tokyo Women s Medical University, Shinjukuku, Tokyo, Japan
    Cancer Chemother Pharmacol 63:85-9. 2008
  3. ncbi ERCC1 codon 118 polymorphism is a useful prognostic marker in patients with pancreatic cancer treated with platinum-based chemotherapy
    Hirotaka Kamikozuru
    Department of Surgery, Institute of Gastroenterology, Tokyo Women s Medical University, Shinjuku ku, Tokyo 162 8666, Japan
    Int J Oncol 32:1091-6. 2008
  4. doi Epidermal growth factor receptor (EGFR) mRNA levels and protein expression levels in primary colorectal cancer and corresponding liver metastases
    Hidekazu Kuramochi
    Department of Gastroenterological Surgery, Tokyo Women s Medical University, 8 1 Kawadacho, Shinjukuku, Tokyo 162 8666, Japan
    Cancer Chemother Pharmacol 65:825-31. 2010
  5. ncbi Combination therapy of S-1 and CDDP for patients with colorectal cancer
    Kazumi Uchida
    Institute of Gastroenterology, Tokyo Women s Medical University, 8 1, Kawada cho, Shinjukuku, Tokyo 162 8666, Japan
    J Cancer Res Clin Oncol 133:841-6. 2007
  6. doi Drug monitoring during FOLFOX6 therapy in a rectal cancer patient on chronic hemodialysis
    Yoshihisa Watayo
    Department of Gastroenterology, Tokyo Women s Medical University, Shinjukuku, Tokyo, Japan
    Jpn J Clin Oncol 40:360-4. 2010
  7. doi Degraded DNA may induce discordance of KRAS status between primary colorectal cancer and corresponding liver metastases
    Yuka Kaneko
    Department of Gastroenterological Surgery, Tokyo Women s Medical University, 8 1 Kawadacho, Shinjuku ku, Tokyo, Japan
    Int J Clin Oncol 19:113-20. 2014
  8. pmc Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase
    Ayako Nakamura
    Field of Chemotherapy on Digestive Organs Division of Gastrointestinal Surgery, Tokyo Women s Medical University Graduate School of Medicine, 8 1 Kawada cho, Shinjuku ku, Tokyo, 162 8666, Japan
    Gastric Cancer 17:188-95. 2014
  9. doi Messenger RNA expression of vascular endothelial growth factor and its receptors in primary colorectal cancer and corresponding liver metastasis
    Hirotoshi Kobayashi
    Department of Surgical Oncology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan
    Ann Surg Oncol 15:1232-8. 2008
  10. ncbi Intratumoral COX-2 gene expression is a predictive factor for colorectal cancer response to fluoropyrimidine-based chemotherapy
    Kazumi Uchida
    Department of Surgery, Institute of Gastroenterology, Tokyo Women s Medical University, Tokyo, Japan
    Clin Cancer Res 11:3363-8. 2005

Collaborators

Detail Information

Publications10

  1. pmc Amphiregulin and Epiregulin mRNA expression in primary colorectal cancer and corresponding liver metastases
    Hidekazu Kuramochi
    Department of Chemotherapy and Palliative Care, Tokyo Women s Medical University, 8 1 Kawadacho, Shinjukuku, Tokyo, Japan
    BMC Cancer 12:88. 2012
    ..The purpose of this study is to determine the correlation of AREG and EREG expression between primary colorectal cancer and corresponding liver metastases...
  2. doi High intratumoral dihydropyrimidine dehydrogenase mRNA levels in pancreatic cancer associated with a high rate of response to S-1
    Hidekazu Kuramochi
    Department of Gastroenterology, Tokyo Women s Medical University, Shinjukuku, Tokyo, Japan
    Cancer Chemother Pharmacol 63:85-9. 2008
    ..Accordingly, intratumoral DPD mRNA expression level was measured to reveal whether the level in pancreatic cancer was different from other GI cancer and whether it was relevant to chemosensitivity...
  3. ncbi ERCC1 codon 118 polymorphism is a useful prognostic marker in patients with pancreatic cancer treated with platinum-based chemotherapy
    Hirotaka Kamikozuru
    Department of Surgery, Institute of Gastroenterology, Tokyo Women s Medical University, Shinjuku ku, Tokyo 162 8666, Japan
    Int J Oncol 32:1091-6. 2008
    ..ERCC1 polymorphism may be a useful prognostic marker in patients with pancreatic cancer treated with platinum-based chemotherapy...
  4. doi Epidermal growth factor receptor (EGFR) mRNA levels and protein expression levels in primary colorectal cancer and corresponding liver metastases
    Hidekazu Kuramochi
    Department of Gastroenterological Surgery, Tokyo Women s Medical University, 8 1 Kawadacho, Shinjukuku, Tokyo 162 8666, Japan
    Cancer Chemother Pharmacol 65:825-31. 2010
    ..Our aim was to determine how EGFR gene expression levels in primary colorectal cancer (CRC) were related to those in liver metastases...
  5. ncbi Combination therapy of S-1 and CDDP for patients with colorectal cancer
    Kazumi Uchida
    Institute of Gastroenterology, Tokyo Women s Medical University, 8 1, Kawada cho, Shinjukuku, Tokyo 162 8666, Japan
    J Cancer Res Clin Oncol 133:841-6. 2007
    ..We evaluate the feasibility and efficacy of S-1 in combination with cisplatin (CDDP) for patients with colorectal cancer...
  6. doi Drug monitoring during FOLFOX6 therapy in a rectal cancer patient on chronic hemodialysis
    Yoshihisa Watayo
    Department of Gastroenterology, Tokyo Women s Medical University, Shinjukuku, Tokyo, Japan
    Jpn J Clin Oncol 40:360-4. 2010
    ..The serum levels of free platinum showed bimodal pattern, and this second peak increased the area under the curve of free platinum. This pattern seems to be unique in patients on hemodialysis...
  7. doi Degraded DNA may induce discordance of KRAS status between primary colorectal cancer and corresponding liver metastases
    Yuka Kaneko
    Department of Gastroenterological Surgery, Tokyo Women s Medical University, 8 1 Kawadacho, Shinjuku ku, Tokyo, Japan
    Int J Clin Oncol 19:113-20. 2014
    ..Previous reports demonstrated approximately 100 % concordance of KRAS status between primary colorectal cancer and liver metastases; however, mismatched KRAS status still occurs...
  8. pmc Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase
    Ayako Nakamura
    Field of Chemotherapy on Digestive Organs Division of Gastrointestinal Surgery, Tokyo Women s Medical University Graduate School of Medicine, 8 1 Kawada cho, Shinjuku ku, Tokyo, 162 8666, Japan
    Gastric Cancer 17:188-95. 2014
    ..Elucidation of the mechanisms by which gastric cancer cells acquire resistance to 5-fluorouracil (5FU) may provide important clues to the development of effective chemotherapy for 5FU-resistant gastric cancer..
  9. doi Messenger RNA expression of vascular endothelial growth factor and its receptors in primary colorectal cancer and corresponding liver metastasis
    Hirotoshi Kobayashi
    Department of Surgical Oncology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan
    Ann Surg Oncol 15:1232-8. 2008
    ..The aim of this study was to clarify the association between messenger RNA (mRNA) levels of vascular endothelial growth factor (VEGF) and its receptors (VEGFR) in primary colorectal cancer and those in corresponding liver metastasis...
  10. ncbi Intratumoral COX-2 gene expression is a predictive factor for colorectal cancer response to fluoropyrimidine-based chemotherapy
    Kazumi Uchida
    Department of Surgery, Institute of Gastroenterology, Tokyo Women s Medical University, Tokyo, Japan
    Clin Cancer Res 11:3363-8. 2005
    ..The purpose of this study was to ascertain if COX-2 gene expression is associated with tumor response in the clinical treatment of colorectal cancer with the fluoropyrimidine-based therapy S-1...